Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 35 - Antineoplastic agents
Patents for A61P 35 - Antineoplastic agents (221,099)
11/2000
11/30/2000WO2000071556A1 Prodrug activation using catalytic antibodies
11/30/2000WO2000071549A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000WO2000071548A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000WO2000071543A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000WO2000071537A1 New pharmaceutically active compounds
11/30/2000WO2000071532A1 Heterocyclic derivatives useful as anticancer agents
11/30/2000WO2000071514A1 α-AMINO-β-SULFONYL HYDROXAMIC ACID COMPOUNDS
11/30/2000WO2000071180A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000WO2000071158A1 Tagged epitope protein transposable element
11/30/2000WO2000071157A2 New vaccine formulations - 1
11/30/2000WO2000071156A2 New vaccine formulations-3
11/30/2000WO2000071155A2 New vaccine formulations - 2
11/30/2000WO2000071150A1 Tumor necrosis factor receptor 5
11/30/2000WO2000071148A2 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000WO2000071135A1 Anti-tumor comprising boroproline compounds
11/30/2000WO2000071134A1 Isophosphoramide mustard analogs and use thereof
11/30/2000WO2000071132A1 Use of 1,4-benzothiazepine derivatives as drugs overcoming carcinostatic tolerance
11/30/2000WO2000071129A1 Pyrrolotriazine inhibitors of kinases
11/30/2000WO2000071121A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations
11/30/2000WO2000071104A2 Use of bisphosphonic acids for treating angiogenesis
11/30/2000WO2000071103A2 Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000WO2000071078A2 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000WO2000050607A3 Goodpasture antigen binding protein
11/30/2000WO2000047719A3 Maturation of dendritic cells with immune response modifying compounds
11/30/2000WO2000047611A3 Polymeric immunoglobulin receptor (pigr)-binding domains and methods of use therefor
11/30/2000WO2000044900A3 Nucleic-acid binding proteins
11/30/2000WO2000044404A3 Methods for inhibiting brain tumor growth by using selected integrin antagonists
11/30/2000WO2000043790A3 Compositions and methods for the diagnosis and treatment of tumor
11/30/2000WO2000043413A3 Pyroglutamic acid derivatives and related compounds which inhibit leukocyte adhesion mediated by vla-4
11/30/2000WO2000043408A3 Steroid sulfatase inhibitors and methods for making and using the same
11/30/2000WO2000042989A3 Novel hydrogel isolated cochleate formulations, process of preparation and their use for the delivery of biologically relevant molecules
11/30/2000WO2000042201A3 Human peptidases
11/30/2000WO2000042172A3 Human homologues of proteins regulated by circadian rhythms
11/30/2000WO2000042072A3 Polypeptide variants with altered effector function
11/30/2000WO2000041687A3 Composition and methods for administration of water-insoluble paclitaxel derivatives
11/30/2000WO2000040605A3 Compositions and methods relating to cyclic compounds that undergo nucleotide base pair-specific interactions with double-stranded nucleic acids
11/30/2000WO2000038716A9 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/30/2000WO2000034338A3 Acetal benzylmaltosides as inhibitors of smooth muscle cell proliferation
11/30/2000WO2000033814A3 Method for administering agents to the central nervous system
11/30/2000WO2000032583A9 Antitumor dibenzofluorene derivatives
11/30/2000WO2000028027A3 Corticosteroid synthesis-associated genes
11/30/2000WO2000027363A9 Aerosols comprising nanoparticle drugs
11/30/2000WO2000025829A3 Radiodense compositions
11/30/2000WO2000025725A3 Functional antagonists of hedgehog activity
11/30/2000WO2000024415A9 Methods for regulating angiogenesis and vascular integrity using trk receptor ligands
11/30/2000WO2000024391A3 Conductance of improperly folded proteins through the secretory pathway
11/30/2000WO2000022136A3 Recombinant e1a deleted adenoviral vectors
11/30/2000WO2000021572A3 Hydrogels and water soluble polymeric carriers for drug delivery
11/30/2000WO2000014119A3 Bifunctional antibodies and their use in targeting anti-tumour agents
11/30/2000DE19924818A1 Substituierte Phenylcyclohexancarbonsäureamide Substituted Phenylcyclohexancarbonsäureamide
11/30/2000DE19924199A1 Tumorassoziiertes Antigen Tumor-associated antigen
11/30/2000DE19923961A1 Verwendung von 15-Deoxyspergualin zur Behandlung von hyperreaktiven entzündlichen Erkrankungen und Autoimmunerkrankungen Use of 15-deoxyspergualin for the treatment of hyperreactive inflammatory diseases and autoimmune diseases
11/30/2000CA2382774A1 Meth1 and meth2 polynucleotides and polypeptides
11/30/2000CA2375072A1 Prodrug activation using catalytic antibodies
11/30/2000CA2374941A1 Composition designed for implementing an antitumoral or antiviral treatment in a mammal
11/30/2000CA2374926A1 Thiazoloderivatives and pharmaceutical compositions containing them
11/30/2000CA2374918A1 Identification of novel mechanisms of drug resistance
11/30/2000CA2374915A1 Substituted imidazothiazoles as antidepressant agents
11/30/2000CA2374714A1 Purine derivatives, preparation method and pharmaceutical compositions containing same
11/30/2000CA2374674A1 Tumor necrosis factor receptor 5
11/30/2000CA2374507A1 Assay for the detection of paclitaxel resistant cells in human tumors
11/30/2000CA2374421A1 High specificity hairpin antisense oligonucleotides
11/30/2000CA2374354A1 Immunogenic peptides derived from mage and the use thereof
11/30/2000CA2374301A1 Therapeutic uses of agents that modulate the activity of alpha-smooth muscle actin
11/30/2000CA2374296A1 Bioadhesive hydrogels with functionalized degradable crosslinks
11/30/2000CA2374070A1 Tagged epitope protein transposable element
11/30/2000CA2374049A1 Use of bisphosphonic acids for treating angiogenesis
11/30/2000CA2374021A1 Methods for regulating protein conformation using molecular chaperones
11/30/2000CA2373751A1 Isoflavonoid methylation enzyme
11/30/2000CA2373693A1 Seven transmembrane receptor genes
11/30/2000CA2373643A1 Anti-tumor comprising boroproline compounds
11/30/2000CA2373577A1 .alpha.-amino-.beta.-sulfonyl hydroxamic acid compounds
11/30/2000CA2372743A1 New pharmaceutically active compounds
11/30/2000CA2371828A1 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer
11/30/2000CA2369933A1 Fap-activated anti-tumor compounds
11/30/2000CA2366408A1 Inhibition of histone deacetylase
11/29/2000EP1055685A1 Non-antigenic branched polymer conjugates
11/29/2000EP1055426A1 Dysuria remedies
11/29/2000EP1055366A1 Use of transgenic mice lacking jun-b expression in the myeloid lineage
11/29/2000EP1054995A1 GABAB-R2a, A 7TM RECEPTOR
11/29/2000EP1054994A2 Fermentative preparation process for cytostatics and crystal forms thereof
11/29/2000EP1054981A2 Prostate-associated serine protease
11/29/2000EP1054980A1 HUMAN HEPARANASE POLYPEPTIDE AND cDNA
11/29/2000EP1054979A1 Compositions and methods for sensitizing and inhibiting growth of human tumor cells
11/29/2000EP1054969A2 Retinoblastoma protein complexes and retinoblastoma interacting proteins
11/29/2000EP1054968A1 Apoptosis inducing molecule ii and methods of use
11/29/2000EP1054962A2 Caf1-related protein
11/29/2000EP1054961A2 Human short-chain tnf-receptor family protein
11/29/2000EP1054958A1 Human serine protease and serpin polypeptides
11/29/2000EP1054904A1 Mucilage, a g-protein-coupled receptor
11/29/2000EP1054900A1 Therapeutic uses of keratinocyte growth factor-2
11/29/2000EP1054899A2 AGENTS FOR TREATING HUMAN ILLNESSES BASED ON $g(b)-CATENIN, AND THE PRODUCTION AND USE THEREOF
11/29/2000EP1054894A1 Breast cancer resistance protein (bcrp) and the dna which encodes it
11/29/2000EP1054890A1 Oligodeoxyribonucleotides comprising o6-benzylguanine and their use
11/29/2000EP1054887A1 Bicyclic pyridine and pyrimidine derivatives as neuropeptide y receptor antagonists
11/29/2000EP1054886A1 Heteroaryl amidines, methylamidines and guanidines as protease inhibitors, in particular as urokinase inhibitors
11/29/2000EP1054882A1 Condensed heterocyclic system derivatives, preparation, pharmaceutical compositions containing them
11/29/2000EP1054877A1 Novel cyclic sulfonamide derivatives as metalloproteinase inhibitors
11/29/2000EP1054871A2 Pyrimidines and triazines as integrin antagonists
11/29/2000EP1054870A1 Heterocyclic topoisomerase poisons
1 ... 1866 1867 1868 1869 1870 1871 1872 1873 1874 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 ... 2211